Stella Chemifa Corporation logo

Stella Chemifa Corporation

4109.T

JPXBasic MaterialsChemicals - Specialty

Latest quote

¥5,510

+¥10.00 · +0.18%

Aug 24, 3:30 PM JST

4109.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Stella Chemifa Corporation, a Japanese company established in 1916 and headquartered in Osaka, specializes as a global manufacturer and supplier of inorganic fluorine compounds. Formerly known as Hashimoto Chemical Corporation until its rebranding in 1997, the company offers a comprehensive product portfolio tailored for diverse industrial applications worldwide. For the electronics sector, Stella Chemifa provides essential materials such as hydrofluoric acid, buffered hydrofluoric acid, and various etching solutions used in the production of semiconductors, liquid crystal displays, and solar cells. It also supplies a range of metal fluorides, including calcium, aluminum, and lithium fluoride, crucial for optical applications, alongside lithium hexafluorophosphate for battery manufacturing. Its offerings extend to numerous boron trifluoride compounds, serving as vital reactive catalysts across different chemical processes. Additionally, the company produces anhydrous hydrofluoric acid and 55% hydrofluoric acid, utilized in surface treatment and as more environmentally conscious alternatives to CFCs. Stella Chemifa also supports the nuclear energy industry with potassium fluoroborate and boric acid, and provides tin fluoride (II) USP for products requiring GMP compliance. Beyond these specialized compounds, the company's extensive catalog includes a broad array of other fluorochemicals, such as fluorosilicic acid, various fluorosilicates, fluoroboric acid, diverse fluoroborates, and a selection of ammonium, sodium, and potassium fluorides. Complementing its manufacturing operations, Stella Chemifa offers logistics services for the transportation of specialized chemical substances, high-pressure gases, and hazardous materials. Demonstrating a commitment to innovation, the company is also actively involved in the development of Boron Neutron Capture therapy for cancer treatment.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
JP
CEO
Aki Hashimoto
Listed since
Jan 4, 2001
Employees
683

Market position

Day range

Current ¥5,510

52-week range

Current ¥5,510

Open
¥5,500
Previous close
¥5,500
Volume
51K
0.55× average
Average volume
92.34K
Average daily volume
Market cap
67.26B JPY
Beta
0.5
Market reference 1
50-day average
¥5,980.4
-7.87% below average
200-day average
¥5,367.25
+2.66% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
47.85B JPY
P/E (TTM)
19.83×
P/B (TTM)
1.41×
P/S (TTM)
1.78×
EV / EBITDA
6.35×
Earnings yield
5.37%
Free cash flow yield
2.51%
Dividend yield
3.27%

Profitability & efficiency

Gross margin
22.92%
Operating margin
12.35%
Net margin
8.80%
Return on equity
6.39%
Return on assets
4.77%
Return on invested capital
5.57%

Financial health

Debt / equity
0.11×
Current ratio
3.18×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends26%19%11%4%Gross margin, FY2021: 23.85%Gross margin, FY2022: 20.94%Gross margin, FY2023: 21.18%Gross margin, FY2024: 22.75%Gross margin, FY2025: 23.32%Operating margin, FY2021: 12.27%Operating margin, FY2022: 9.93%Operating margin, FY2023: 8.94%Operating margin, FY2024: 11.96%Operating margin, FY2025: 12.62%Net margin, FY2021: 14.38%Net margin, FY2022: 6.44%Net margin, FY2023: 6.06%Net margin, FY2024: 7.97%Net margin, FY2025: 8.31%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 23.85%. Gross margin FY2022 20.94%. Gross margin FY2023 21.18%. Gross margin FY2024 22.75%. Gross margin FY2025 23.32%. Operating margin FY2021 12.27%. Operating margin FY2022 9.93%. Operating margin FY2023 8.94%. Operating margin FY2024 11.96%. Operating margin FY2025 12.62%. Net margin FY2021 14.38%. Net margin FY2022 6.44%. Net margin FY2023 6.06%. Net margin FY2024 7.97%. Net margin FY2025 8.31%.

Income trends

Revenue

36.8B JPY+1.41%

Operating income

4.65B JPY+7.05%

Net income

3.06B JPY+5.78%
Income trends across reported periods40.84B JPY26.66B JPY12.48B JPY−1.7B JPYRevenue, FY2021: 37.3B JPYRevenue, FY2022: 35.38B JPYRevenue, FY2023: 30.45B JPYRevenue, FY2024: 36.29B JPYRevenue, FY2025: 36.8B JPYOperating income, FY2021: 4.58B JPYOperating income, FY2022: 3.51B JPYOperating income, FY2023: 2.72B JPYOperating income, FY2024: 4.34B JPYOperating income, FY2025: 4.65B JPYNet income, FY2021: 5.36B JPYNet income, FY2022: 2.28B JPYNet income, FY2023: 1.85B JPYNet income, FY2024: 2.89B JPYNet income, FY2025: 3.06B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 37.3B JPY. Revenue FY2022 35.38B JPY. Revenue FY2023 30.45B JPY. Revenue FY2024 36.29B JPY. Revenue FY2025 36.8B JPY. Operating income FY2021 4.58B JPY. Operating income FY2022 3.51B JPY. Operating income FY2023 2.72B JPY. Operating income FY2024 4.34B JPY. Operating income FY2025 4.65B JPY. Net income FY2021 5.36B JPY. Net income FY2022 2.28B JPY. Net income FY2023 1.85B JPY. Net income FY2024 2.89B JPY. Net income FY2025 3.06B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue36.8B JPY36.29B JPY30.45B JPY35.38B JPY37.3B JPY
Cost of goods sold28.22B JPY28.03B JPY24B JPY27.97B JPY28.4B JPY
Gross profit8.58B JPY8.26B JPY6.45B JPY7.41B JPY8.9B JPY
Research and development597M JPY698M JPY660M JPY744M JPY
Selling, general, and administrative3.94B JPY3.32B JPY3.03B JPY3.24B JPY3.57B JPY
Operating expenses3.94B JPY3.92B JPY3.72B JPY3.9B JPY4.32B JPY
Interest income87M JPY107M JPY79M JPY34M JPY10M JPY
Interest expense74M JPY39M JPY30M JPY32M JPY35M JPY
Depreciation and amortization2.89B JPY2.81B JPY2.77B JPY2.59B JPY2.71B JPY
Operating income4.65B JPY4.34B JPY2.72B JPY3.51B JPY4.58B JPY
Net income3.06B JPY2.89B JPY1.85B JPY2.28B JPY5.36B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
89.67

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates95.7467.7239.711.68Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 8, 2024: actual 70.34, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 88.7, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 9, 2025: actual 13.74, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 7, 2025: actual 70.21, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 74.15, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 59.74, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 54.35, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 6, 2026: actual 89.67, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates10.54B9.72B8.91B8.09BQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 8.49B JPY, estimate 9.23B JPY, surprise -8.00%, Miss. Q2 2025, reported May 9, 2025: actual 9.64B JPY, estimate 9.02B JPY, surprise +6.84%, Beat. Q3 2025, reported Aug 7, 2025: actual 8.8B JPY, estimate 8.69B JPY, surprise +1.17%, Beat. Q4 2025, reported Nov 13, 2025: actual 9.36B JPY, estimate 8.89B JPY, surprise +5.37%, Beat. Q1 2026, reported Feb 12, 2026: actual 8.81B JPY, estimate 9.4B JPY, surprise -6.32%, Miss. Q2 2026, reported May 14, 2026: actual 9.84B JPY, estimate 9.14B JPY, surprise +7.65%, Beat. Q3 2026, reported Aug 6, 2026: actual 9.75B JPY, estimate 9.55B JPY, surprise +2.14%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 10.14B JPY, surprise —, Comparison unavailable.

4109.T peers

ETFs holding 4109.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 4109.T

research.disclaimer